Home › Urotheelcelcarcinoom (overgangscelcarcinoom) › Texas › Austin
Urotheelcelcarcinoom (overgangscelcarcinoom) klinische studies in Austin, TX
10 studies voor Urotheelcelcarcinoom (overgangscelcarcinoom) zoeken deelnemers op locaties in en rond Austin (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- NEXT Austin, Austin
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #46, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RekruterenFase 3
- Texas Oncology, Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruterenFase 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruterenFase 3
- USO-Texas Oncology-Central/South Texas, Austin
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
RekruterenFase 3
- Texas Urology Specialists-Austin, Austin
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
RekruterenFase 1
- NEXT Oncology, Austin, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Rekruteren
- Austin Urology Institute, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology, Austin, TX 78758
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Austin
Urotheelcelcarcinoom (overgangscelcarcinoom) studies in andere steden
- Nashville, TN23 studies
- New York City, NY22 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- San Antonio, TX11 studies
- Boston, MA11 studies
- Orange, CA10 studies
Andere studies in Austin
- Niet-kleincellige longkanker30 studies
- Kanker (alle vormen)20 studies
- Obesitas20 studies
- Metastatische kanker19 studies
- Colorectale kanker19 studies
- Hartfalen18 studies
- Borstkanker18 studies
- Overgewicht18 studies
- Eierstokkanker17 studies
- Endometriumkanker15 studies
- Prostaatkanker15 studies
- Depressie14 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.